Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Net Cash Flow (2018 - 2025)

Historic Net Cash Flow for Neurogene (NGNE) over the last 6 years, with Q3 2025 value amounting to $12.2 million.

  • Neurogene's Net Cash Flow rose 12746.01% to $12.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.4 million, marking a year-over-year decrease of 7962.63%. This contributed to the annual value of -$11.8 million for FY2024, which is 11768.15% down from last year.
  • Latest data reveals that Neurogene reported Net Cash Flow of $12.2 million as of Q3 2025, which was up 12746.01% from -$11.9 million recorded in Q2 2025.
  • Neurogene's Net Cash Flow's 5-year high stood at $103.2 million during Q4 2023, with a 5-year trough of -$65.8 million in Q1 2025.
  • Over the past 3 years, Neurogene's median Net Cash Flow value was -$11.9 million (recorded in 2025), while the average stood at -$970636.4.
  • Data for Neurogene's Net Cash Flow shows a peak YoY increase of 12746.01% (in 2025) and a maximum YoY decrease of 394810.05% (in 2025) over the last 5 years.
  • Quarter analysis of 3 years shows Neurogene's Net Cash Flow stood at $103.2 million in 2023, then crashed by 32.22% to $70.0 million in 2024, then crashed by 82.57% to $12.2 million in 2025.
  • Its Net Cash Flow was $12.2 million in Q3 2025, compared to -$11.9 million in Q2 2025 and -$65.8 million in Q1 2025.